Today we introduce three new mouse monoclonal antibody clones, that have been added to our portfolio: Anti-human CD96 (clone NK92.39), anti-human CD155 (clone SKII.4), and anti-human CD369 (clone 15E2).
Determination of cytokeratine content has become an important tool in classification of tumor cells. The patterns of cytokeratins of a given type of carcinoma appear to be identical in primary tumors and metastases, independent from the specific location and size.
Recombinant allergens are produced both in prokaryotic (mainly E. coli) and in eukaryotic (yeast and insect cells) expression systems and in addition to their use in diagnostics find their way also into immunotherapy of various allergies.
Today we introduce two new antibody clones, that have been added to our portfolio:
Anti-histone deacetylase 6 (HDAC6) - clone 159
Anti-human CD51/CD61 complex (extracellular epitope) - clone 23C6
The mouse monoclonal antibody JOVI.1, recognizing an extracellular epitope on TCR Cbeta1 (TRBC1), is suitable for flow cytometry, immunoprecipitation, and immunohistochemistry (frozen sections). It is popular as a tool for analysis of T cell-mediated diseases.
We are proud to inform you that in March 2020 in Cytometry B (Clinical cytometry) a paper was released having one of our colleagues from EXBIO Praha team Miro Benko (Director, Product Development Department) as a co-author.
Recently developed strategy for prevention of cancer relapse due to acquired radioresistance may be based on immunotherapies. One promising approach is based on genetically modified T cells expressing chimeric antigen receptors (CAR).
EXBIO the leading manufacturer of monoclonal antibodies and reagents for research and clinical applications with the focus on multi-color flow cytometry analysis of human cellular markers, is pleased to announce its acquisition of Apronex